JP2009537624A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009537624A5 JP2009537624A5 JP2009511581A JP2009511581A JP2009537624A5 JP 2009537624 A5 JP2009537624 A5 JP 2009537624A5 JP 2009511581 A JP2009511581 A JP 2009511581A JP 2009511581 A JP2009511581 A JP 2009511581A JP 2009537624 A5 JP2009537624 A5 JP 2009537624A5
- Authority
- JP
- Japan
- Prior art keywords
- abu
- cbp
- contrast agent
- peptide
- ily
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 claims 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims 11
- 239000002872 contrast media Substances 0.000 claims 9
- 238000003384 imaging method Methods 0.000 claims 6
- 229920001223 polyethylene glycol Polymers 0.000 claims 6
- 125000003636 chemical group Chemical group 0.000 claims 4
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 4
- 239000002243 precursor Substances 0.000 claims 4
- 235000018417 cysteine Nutrition 0.000 claims 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 3
- 238000001727 in vivo Methods 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims 3
- 230000002285 radioactive effect Effects 0.000 claims 3
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- -1 alkyl tosylate Chemical compound 0.000 claims 2
- 229910021645 metal ion Inorganic materials 0.000 claims 2
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 125000003295 alanine group Chemical class N[C@@H](C)C(=O)* 0.000 claims 1
- 150000001350 alkyl halides Chemical class 0.000 claims 1
- 235000009697 arginine Nutrition 0.000 claims 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 238000003776 cleavage reaction Methods 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 230000000536 complexating effect Effects 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000004132 cross linking Methods 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 125000003827 glycol group Chemical group 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 238000011503 in vivo imaging Methods 0.000 claims 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 229930182817 methionine Natural products 0.000 claims 1
- 229910052755 nonmetal Inorganic materials 0.000 claims 1
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims 1
- 238000012634 optical imaging Methods 0.000 claims 1
- 125000002524 organometallic group Chemical group 0.000 claims 1
- 230000005298 paramagnetic effect Effects 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 claims 1
- 230000007017 scission Effects 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 239000004474 valine Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0610395.6A GB0610395D0 (en) | 2006-05-25 | 2006-05-25 | Novel imaging agents |
| PCT/GB2007/001964 WO2007138291A2 (en) | 2006-05-25 | 2007-05-25 | Novel imaging agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009537624A JP2009537624A (ja) | 2009-10-29 |
| JP2009537624A5 true JP2009537624A5 (enExample) | 2010-06-17 |
Family
ID=36687722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511581A Ceased JP2009537624A (ja) | 2006-05-25 | 2007-05-25 | 新規造影剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8304388B2 (enExample) |
| EP (1) | EP2026844A2 (enExample) |
| JP (1) | JP2009537624A (enExample) |
| CN (1) | CN101454026B (enExample) |
| BR (1) | BRPI0711937A2 (enExample) |
| GB (1) | GB0610395D0 (enExample) |
| RU (1) | RU2441668C2 (enExample) |
| WO (1) | WO2007138291A2 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009074628A1 (en) * | 2007-12-13 | 2009-06-18 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Polypeptides, cyclic polypeptides and pharmaceutical comprising thereof for non invasive specific imaging of fibrosis |
| LT2280720T (lt) | 2008-03-27 | 2019-07-25 | Purdue Research Foundation | Kolageną surišantys sintetiniai peptidoglikanai, jų paruošimas ir naudojimo būdai |
| JP2010215572A (ja) * | 2009-03-17 | 2010-09-30 | Japan Health Science Foundation | 歯髄炎診断マーカー及び歯髄炎診断システム |
| WO2011128931A1 (ja) * | 2010-04-12 | 2011-10-20 | 財団法人ヒューマンサイエンス振興財団 | 歯髄炎診断マーカー及び歯髄炎診断システム |
| US9173919B2 (en) * | 2011-02-16 | 2015-11-03 | Purdue Research Foundation | Collagen-targeted nanoparticles |
| SG195114A1 (en) | 2011-05-24 | 2013-12-30 | Purdue Research Foundation | Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use |
| WO2014055253A1 (en) * | 2012-10-04 | 2014-04-10 | The General Hospital Corporation | Methods of synthesizing and using peg-like fluorochromes |
| EP2970509B1 (en) | 2013-03-15 | 2020-05-13 | Purdue Research Foundation | Extracellular matrix-binding synthetic peptidoglycans |
| EP4091624A1 (en) | 2013-03-15 | 2022-11-23 | Protagonist Therapeutics, Inc. | Hepcidin analogues and uses thereof |
| US20140294902A1 (en) * | 2013-04-02 | 2014-10-02 | Protagonist Therapeutics, Inc. | Novel a4b7 peptide antagonists |
| US20140294901A1 (en) * | 2013-04-02 | 2014-10-02 | Protagonist Therapeutics, Inc. | Novel a4b7 peptide dimer antagonists |
| US10772931B2 (en) | 2014-04-25 | 2020-09-15 | Purdue Research Foundation | Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction |
| CA2949215C (en) | 2014-05-16 | 2023-03-14 | Protagonist Therapeutics, Inc. | .alpha.4.beta.7 integrin thioether peptide antagonists |
| EP4378536A3 (en) | 2014-07-17 | 2024-10-09 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| SG11201702553RA (en) | 2014-10-01 | 2017-04-27 | Protagonist Therapeutics Inc | NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS |
| EP3201217A4 (en) | 2014-10-01 | 2018-07-18 | Protagonist Therapeutics Inc. | Novel cyclic monomer and dimer peptides having integrin antagonist activity |
| US10953104B2 (en) | 2015-01-30 | 2021-03-23 | University Of Utah Research Foundation | Dimeric collagen hybridizing peptides and methods of using |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2017117411A1 (en) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| EP3445402A4 (en) * | 2016-04-21 | 2019-12-11 | The Board Of Regents Of The University Of Texas System | METHOD AND COMPOSITIONS FOR DETECTING ANEURYSMS |
| AU2018298224B2 (en) | 2017-07-07 | 2024-08-15 | Symic Ip, Llc | Synthetic bioconjugates |
| JP7174429B2 (ja) * | 2017-08-31 | 2022-11-17 | 学校法人早稲田大学 | コラーゲンへの結合活性を有する環状ペプチド |
| EP4092038A1 (en) | 2017-09-11 | 2022-11-23 | Protagonist Therapeutics, Inc. | Opioid agonist peptides and uses thereof |
| CA3089868A1 (en) | 2018-02-08 | 2019-08-15 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| KR20220044277A (ko) | 2019-07-10 | 2022-04-07 | 프로타고니스트 테라퓨틱스, 인코포레이티드 | 인터루킨-23 수용체의 펩티드 억제제 및 염증성 질환을 치료하기 위한 이의 용도 |
| WO2021146454A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2021146441A1 (en) | 2020-01-15 | 2021-07-22 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| EP4247403A4 (en) | 2020-11-20 | 2024-12-11 | JANSSEN Pharmaceutica NV | COMPOSITIONS OF PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR |
| JP2024525732A (ja) | 2021-07-14 | 2024-07-12 | ヤンセン バイオテツク，インコーポレーテツド | インターロイキン－２３受容体の脂質化ペプチド阻害剤 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5972890A (en) | 1988-05-02 | 1999-10-26 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
| EP0635029A4 (en) | 1992-04-10 | 1996-01-24 | Gen Hospital Corp | MATRIX PROTEIN FROM CARTILAGE AND APPLICATION METHODS. |
| US7488792B2 (en) | 2002-08-28 | 2009-02-10 | Burnham Institute For Medical Research | Collagen-binding molecules that selectively home to tumor vasculature and methods of using same |
| GB0326546D0 (en) * | 2003-11-14 | 2003-12-17 | Amersham Plc | Inhibitor imaging agents |
| GB0327494D0 (en) | 2003-11-26 | 2003-12-31 | Amersham Plc | Novel imaging agents |
| CA2575416A1 (en) | 2004-02-27 | 2005-09-09 | The University Of Western Ontario | Bone sialoprotein collagen-binding peptides |
| US7575738B2 (en) | 2004-08-13 | 2009-08-18 | General Electric Company | Heat shock protein as a targeting agent for endothelium-specific in vivo transduction |
| GB0421308D0 (en) | 2004-09-24 | 2004-10-27 | Amersham Plc | Enzyme inhibitor imaging agents |
| US8182790B2 (en) * | 2004-11-22 | 2012-05-22 | Ge Healthcare As | Contrast agents |
-
2006
- 2006-05-25 GB GBGB0610395.6A patent/GB0610395D0/en not_active Ceased
-
2007
- 2007-05-25 EP EP07732982A patent/EP2026844A2/en not_active Withdrawn
- 2007-05-25 RU RU2008146031/15A patent/RU2441668C2/ru not_active IP Right Cessation
- 2007-05-25 BR BRPI0711937-2A patent/BRPI0711937A2/pt not_active IP Right Cessation
- 2007-05-25 CN CN2007800192052A patent/CN101454026B/zh not_active Expired - Fee Related
- 2007-05-25 JP JP2009511581A patent/JP2009537624A/ja not_active Ceased
- 2007-05-25 US US12/302,290 patent/US8304388B2/en not_active Expired - Fee Related
- 2007-05-25 WO PCT/GB2007/001964 patent/WO2007138291A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009537624A5 (enExample) | ||
| JP5784911B2 (ja) | ボンベシンアナログペプチドアンタゴニスト複合体 | |
| RU2008146031A (ru) | Новые визуализирующие агенты | |
| JP6824738B2 (ja) | 放射性トレーサー組成物及び方法 | |
| CN111183146A (zh) | 高亲和力选择性结合cxcr4的缀合物及其使用方法 | |
| WO2020210919A1 (en) | Novel radiolabelled cxcr4-targeting compounds for diagnosis and therapy | |
| KR20140012112A (ko) | 테크네튬 표지화 펩티드 | |
| JP2019196356A (ja) | 精製方法及び組成物 | |
| JP6231882B2 (ja) | 放射性コンジュゲーション方法 | |
| KR102046437B1 (ko) | 방사성불소화 방법 | |
| JP6574997B2 (ja) | 金属錯体とそのフッ素化 | |
| JP2006508084A (ja) | Ｔｃ錯体と標的部分との複合体並びにＭＲＩ診断での使用 | |
| JP2016532700A (ja) | 放射性標識方法 | |
| CN117396491A (zh) | 基于肽的新型诊断剂和治疗剂 | |
| JP6410339B2 (ja) | 放射性核種標識オクトレオチド誘導体 | |
| JP6280507B2 (ja) | キレート剤 | |
| AU2020291197A1 (en) | Compounds and methods of use | |
| JP4318985B2 (ja) | ソマトスタチンアナログ誘導体およびその利用 | |
| CN114845742A (zh) | 用于癌症成像和治疗的经改性的grpr拮抗剂肽 | |
| CN108697767A (zh) | 包含用于成像目的的螯合部分的选择性胰高血糖素受体激动剂 | |
| CN104854126A (zh) | 多肽及成像方法 | |
| CN119630622A (zh) | 用于放射性药物的硅系氟化物受体基团 | |
| WO2014096191A1 (en) | Bis 2h-imidazole-2-thione chelating agents as ligands for radiopharmaceutical in vivo imaging | |
| CN105339013A (zh) | 金属络合物及其氟化 | |
| EP3490614A1 (en) | Radiopaque compound containing diiodotyrosine |